Nanjing Pharmaceutical Group Company Limited (SHA:600713)

SHA:600713 Revenue

Nanjing Pharmaceutical Group Company had revenue of 13.17B CNY in the quarter ending September 30, 2025, a decrease of -3.93%. This brings the company's revenue in the last twelve months to 53.89B, down -0.16% year-over-year. In the year 2024, Nanjing Pharmaceutical Group Company had annual revenue of 53.70B with 0.20% growth.

• Revenue (ttm): 53.89B
• Revenue Growth: -0.16%
• P/S Ratio: 0.13
• Revenue / Employee: 11.16M
• Employees: 4,830
• Market Cap: 7.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.70B	106.51M	0.20%
Dec 31, 2023	53.59B	3.37B	6.71%
Dec 31, 2022	50.22B	5.10B	11.30%
Dec 31, 2021	45.12B	5.31B	13.33%
Dec 31, 2020	39.82B	2.66B	7.16%